Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of
the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of …

Background The COVID-19 pandemic caused by SARS-COV-2 began in Wuhan, China in
December 2019. Reports of COVID-19 with central (CNS) and peripheral nervous (PNS) …

Guillain-Barré syndrome is a heterogeneous disorder regarding the clinical presentation,
electrophysiological subtype and outcome. Previous single country reports indicate that …

In the wake of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic, an increasing number of patients with neurological disorders, including Guillain …

Background and Objectives Infections play a key role in the development of Guillain-Barré
syndrome (GBS) and have been associated with specific clinical features and disease …

Inflammatory neuropathies are a heterogeneous group of rare diseases of the peripheral
nervous system that include acute and chronic diseases, such as Guillain-Barré syndrome …

Objective To investigate the spectrum of antecedent infections in Chinese patients with
Guillain‐Barré syndrome (GBS) and analyze the infections‐related clinical phenotypes …

Objective To study baseline serum neurofilament light chain (sNfL) levels as a prognostic
biomarker in Guillain-Barré syndrome (GBS). Methods We measured NfL in serum (98 …

Objective To define the current treatment practice of Guillain-Barré syndrome (GBS).
Methods The study was based on prospective observational data from the first 1,300 …

Background and Objectives The clinical course and outcome of the Guillain-Barré syndrome
(GBS) are diverse and vary among regions. The modified Erasmus GBS Outcome Score …